Omni International Corp. – Trademark Portfolio
Entity Type: 03
Omni International Corp. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 8 filings in this category. The portfolio also extends into Class 21 (Housewares) across 4 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include OI, OMNISAFE, OMNITRUST, OMNISHIELD, and OMNI SHIELD. The owner is based in Bedford, NH.
35 Constitution Drive, Suite 1D
Bedford, NH 03110
Showing of trademarks Trademarks
Trademark Classifications
Omni International Corp.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Omni International Corp. have?
Omni International Corp. has 14 U.S. trademarks filed with the USPTO. Of these, 13 registered, 1 cancelled.
What trademark classes does Omni International Corp. file in?
Omni International Corp. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 21 (Housewares), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Omni International Corp.'s most well-known trademarks?
Omni International Corp.'s registered trademark portfolio includes well-known marks such as OI, OMNISAFE, OMNITRUST, OMNISHIELD, and OMNI SHIELD. These are among 13 currently registered trademarks in the portfolio.
What is Omni International Corp.'s trademark registration success rate?
Omni International Corp. has a 93% trademark registration rate, with 13 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.